Drug recall D-0178-2024
Product
Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch G104819
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Doxycycline – drug information
- NDC 68180-650 Doxycycline · Doxycycline 50 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-652 Doxycycline · Doxycycline 100 mg/1 · Lupin Pharmaceuticals, Inc.